Stent News and Research

RSS

A stent is a small mesh tube that’s used to treat narrowed or weakened arteries in the body.

You may have a stent placed in an artery as part of a procedure called angioplasty (AN-jee-oh-plas-tee). Angioplasty can restore blood flow through narrowed or blocked arteries. Stents help prevent arteries from becoming narrowed or blocked again in the months or years after treatment with angioplasty. You may also have a stent placed in a weakened artery to improve blood flow and to help prevent the artery from bursting.

Stents are usually made of metal mesh, but sometimes they’re made of fabric. Fabric stents, also called stent grafts, are used in larger arteries. Some stents are coated with medicines that are slowly and continuously released into the artery. These medicines help prevent the artery from becoming blocked again.

Medtronic launches new device to improve minimally-invasive treatment of thoracic aortic aneurysms

Extending an unmatched record of innovation in the field of endovascular aortic repair, Medtronic, Inc., today announced the U.S. market launch of the Talent Thoracic Stent Graft on the Xcelerant Delivery System, which makes minimally-invasive treatment of thoracic aortic aneurysms easier to perform.

22 Oct 2008

New devices used to reduce arterial occlusions, provide cardiac support

Research results highlighting three new devices used to reduce blockages in peripheral and coronary arteries and to provide cardiac support will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).

12 Oct 2008

FDA approves second-generation TAXUS Liberte Paclitaxel-Eluting Coronary Stent System

Boston Scientific Corporation has announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its second-generation TAXUS Liberte Paclitaxel-Eluting Coronary Stent System.

12 Oct 2008

A little alcohol goes a longer way in women than in men

Alcohol can be a boon or a bane for health. The difference lies in the dose - a little is good, a lot is bad. But the dividing line between a little and a lot differs from person to person. It depends on many things, including sex.

6 Oct 2008

First patient enrolled in study evaluating S.M.A.R.T. Nitinol self-expandable stent

Cordis Corporation has announced the first patient enrollment in the STROLL trial, which will evaluate the safety and efficacy of the S.M.A.R.T. Nitinol Self-Expandable Stent System in treating patients with obstructive superficial femoral artery (SFA) disease, also known as SFA atherosclerosis.

2 Sep 2008

The role played by drug-eluting stents in reducing acute myocardial infarction

The safety debate about drug-eluting stents (DES) is still ongoing. In these times of uncertainty about DES safety, the study has shown that DES markedly improve long-term survival compared to modern bare-metal stents (BMS) implantation in patients with acute ST-segment elevation myocardial infarction (STEMI). In our four year investigation, DES demonstrated a significant reduction of mortality in this sick patient subset.

2 Sep 2008

Researchers say heart bypass a better option than drug-eluting stents

Major clinical research has found that for many patients with clogged arteries, bypass surgery is a better option than drug-eluting stents.

2 Sep 2008

New generation drug-eluting stent demonstrates equivalent efficacy to market leader in 'real world'

In the first study of its kind, a drug-eluting stent (DES) with a biodegradable polymer applied only to the outer surface has been demonstrated as safe and effective as one of the most established and widely used types of DES with a durable polymer, in equivalent conditions to everyday clinical practice.

1 Sep 2008

Drug eluting stents: New elements in the debate

Results announced at the 2006 ESC meeting in Barcelona questioned the long-term safety of drug eluting stents (DES) and sparked intense discussion.

31 Aug 2008

Best use of drug-eluting stents: When should they be avoided?

Compared with bare metal stents, drug-eluting stents substantially reduce the risk of angiographic and clinical recurrence but do not affect mortality or the short term or long term risk of myocardial infarction.

31 Aug 2008

Urologist is first in the world to use robot-assisted surgery to repair rare defect

A urologist at Wake Forest University Baptist Medical Center is the first in the world to repair a rare type of hernia using robot-assisted, minimally invasive surgery. The surgery required only an 18-hour hospital stay; typically, the repair involves major surgery and three to five days of hospital care.

31 Aug 2008

Corn protein, zein being researched for drug delivery

The key to a better drug delivery method for cancer patients may be growing all across the Midwest, South Dakota State University research suggests.

29 Jul 2008

93-year old man with life threatening aneurysm treated using new fenestrated endograft stent

In a New York City metro-area first, a 93-year-old Bronx man underwent implantation of a new stent graft at NewYork-Presbyterian Hospital, the only center on the Eastern Seaboard with access to this investigational device. The new stent graft was implanted under an FDA-approved clinical trial protocol.

7 Jul 2008

Safer, more effective stents will be available next week for patients with clogged arteries

Wake Forest University Baptist Medical Center will be one of the first medical centers in the region to begin using a new generation of drug-coated stents next week following a major study and the Food and Drug Administration's approval of their use.

3 Jul 2008

Drug-releasing coronary artery stent use linked with decrease in procedures to unblock coronary arteries

The widespread adoption of the use of drug-releasing coronary artery stents into routine practice is associated with a decrease in the need for repeat procedures to unblock coronary arteries and also do not appear to increase the risk of death, compared to bare-metal stents, according to a study in the June 25 issue of JAMA, the Journal of the American Medical Association

24 Jun 2008

New perspective on coronary disease thanks to ultrasound

Compared to other techniques, Intravascular Ultrasound (IVUS) is much better at monitoring the increase or decrease of atherosclerosis in the coronary arteries. Can the method even be used to predict the odds of a heart attack or other cardiovascular event? Studies indicate this may be the case, states Professor Clemens von Birgelen in his inaugural address at the University of Twente.

5 Jun 2008

Two Penn studies show drug-eluting stents outperform bare metal stents

The more than ten million Americans who've received drug-eluting stents to open their blocked coronary arteries have a bright future, according to new research from the University of Pennsylvania School of Medicine.

22 May 2008

Study finds new generation of drug-coated stent benefits heart patients

A two-year study comparing a new generation drug-coated stent, XIENCE, with a currently used drug eluting stent, TAXUS, has found that the XIENCE stent had superior benefits in more than 1,000 patients and is better at keeping the arteries of chest pain patients clear of blood clots.

15 May 2008

Physician Gainsharing programs reduce hospital spending

Giving physicians cash payments for reduced hospital spending can help control costs without sacrificing quality or access to care, researchers report in a study released today in the May/June 2008 issue of the journal Health Affairs. The issue is a thematic volume on health reform supported by a grant from the Robert Wood Johnson Foundation.

13 May 2008

Boston Scientific announces dismissal of Johnson and Johnson patent lawsuit in Canada

Boston Scientific Corporation announced today that the Canadian Federal Court has issued judgment in a lawsuit in which Johnson & Johnson had accused the Company's NIR(R) stent of infringing two Johnson & Johnson Palmaz patents.

8 May 2008

Stent News and Research

Further Reading

Medtronic launches new device to improve minimally-invasive treatment of thoracic aortic aneurysms

New devices used to reduce arterial occlusions, provide cardiac support

FDA approves second-generation TAXUS Liberte Paclitaxel-Eluting Coronary Stent System

A little alcohol goes a longer way in women than in men

First patient enrolled in study evaluating S.M.A.R.T. Nitinol self-expandable stent

The role played by drug-eluting stents in reducing acute myocardial infarction

Researchers say heart bypass a better option than drug-eluting stents

New generation drug-eluting stent demonstrates equivalent efficacy to market leader in 'real world'

Drug eluting stents: New elements in the debate

Best use of drug-eluting stents: When should they be avoided?

Urologist is first in the world to use robot-assisted surgery to repair rare defect

Corn protein, zein being researched for drug delivery

93-year old man with life threatening aneurysm treated using new fenestrated endograft stent

Safer, more effective stents will be available next week for patients with clogged arteries

Drug-releasing coronary artery stent use linked with decrease in procedures to unblock coronary arteries

New perspective on coronary disease thanks to ultrasound

Two Penn studies show drug-eluting stents outperform bare metal stents

Study finds new generation of drug-coated stent benefits heart patients

Physician Gainsharing programs reduce hospital spending

Boston Scientific announces dismissal of Johnson and Johnson patent lawsuit in Canada

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News